Contact Us to Learn more about 340B Program Compliance and Savings from Sentry
What does HRSA’s withdrawal of the 340B mega-reg really mean?
HRSA’s latest action is not so much the end of the story as it is the start of a new chapter. We’ll have to stay tuned to see how it plays ...
The orphan drug exclusion: where do things stand?
If you’re confused over the status of the 340B orphan drug exclusion, and how it affects participating free-standing cancer hospitals (CAN), ...
RAND Report clarifies 340B Program impact and provides insights into preserving long-term viability
Last year, Sentry provided support for a recently-published RAND report intended to clarify the 340B Program's purpose, value and extent. The ...
Sentry streamlines 340B program management for pharmacies with their 340B Technology Backbone
Sentry Data Systems announced today that they’re making available to pharmacies their industry-leading, proprietary 340B platform via a new ...
Annual hospital recertification now underway
All hospitals with an active 340B ID as of July 1 are required to recertify to maintain their 340B eligibility.